| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 8e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |